Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men

被引:0
|
作者
Ahayi, S. [1 ]
Chun, F. K. H. [1 ]
Haese, A. [1 ]
Steuber, T. [1 ]
Schlomm, T. [1 ]
Briganti, A. [2 ]
Gallina, A. [2 ]
Montorsi, F. [2 ]
Graefen, M. [3 ]
Huland, H. [3 ]
Karakiewicz, P. I. [4 ]
机构
[1] Univ Hamburg, Dept Urol, Hamburg, Germany
[2] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Urol, Milan, Italy
[3] Univ Hamburg, Martini Clin Prostate Canc Ctr, Hamburg, Germany
[4] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Dept Urol, Montreal, PQ, Canada
关键词
D O I
10.1016/S1569-9056(08)60937-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
939
引用
收藏
页码:306 / 306
页数:1
相关论文
共 50 条
  • [31] Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen, Derrick J.
    Falzarano, Sara M.
    McKenney, Jesse K.
    Przybycin, Chris G.
    Reynolds, Jordan P.
    Roma, Andres
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    Magi-Galluzzi, Cristina
    BJU INTERNATIONAL, 2015, 116 (02) : 220 - 229
  • [32] Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer
    Sarkar, Reith R.
    Bryant, Alex K.
    Parsons, J. Kellogg
    Ryan, Stephen T.
    Kader, A. Karim
    Kane, Christopher J.
    McKay, Rana R.
    Sandhu, Ajay
    Murphy, James D.
    Rose, Brent S.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 584 - 588
  • [33] Insignificant prostate cancer in radical prostatectomy specimen: Time trends and preoperative prediction
    Augustin, H
    Hammerer, PG
    Graefen, M
    Erbersdobler, A
    Blonski, J
    Palisaar, J
    Daghofer, F
    Huland, H
    EUROPEAN UROLOGY, 2003, 43 (05) : 455 - 460
  • [34] ‘Insignificant’ prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy
    P A S Johnstone
    P J Rossi
    A B Jani
    V Master
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 237 - 241
  • [35] Insignificant prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy
    Johnstone, P. A. S.
    Rossi, P. J.
    Jani, A. B.
    Master, V.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (03) : 237 - 241
  • [36] pT0 after radical prostatectomy: Overtreatment for insignificant prostate cancer?
    Hammerer, P
    EUROPEAN UROLOGY, 2004, 45 (01) : 35 - 35
  • [37] Combined PSA density and biopsy features to predict "clinically insignificant" prostate cancer
    Loeb, Stacy
    Roehl, Kimberly A.
    Thaxton, C. Shad
    Cashy, John P.
    Gashti, Sara N.
    Griffin, Christopher R.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 338 - 339
  • [38] A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese men
    Egawa, S
    Suyama, K
    Arai, Y
    Matsumoto, K
    Tsukayama, C
    Kuwao, S
    Baba, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (02) : 74 - 81
  • [39] Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
    Naief Dahran
    Magdalena Szewczyk-Bieda
    Cheng Wei
    Sarah Vinnicombe
    Ghulam Nabi
    Scientific Reports, 7
  • [40] Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men
    Lee, Sang E.
    Kim, Dae S.
    Lee, Won K.
    Park, Hong Z.
    Lee, Chang J.
    Doo, Seung H.
    Jeong, Seong J.
    Yoon, Cheol Y.
    Byun, Seok-Soo
    Choe, Gheeyoung
    Hwang, Sung I.
    Lee, Hak J.
    Hong, Sung K.
    BJU INTERNATIONAL, 2010, 105 (11) : 1526 - 1530